Fibrinolytic Mechanism, Biochemistry, and Preclinical Pharmacology of Recombinant Prourokinase
- 30 November 1995
- journal article
- review article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 6 (6) , 8S-18S
- https://doi.org/10.1016/s1051-0443(95)71242-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1994
- Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosisThe American Journal of Cardiology, 1994
- Composition and susceptibility to thrombolysis of human arterial thrombi and the influence of their ageBlood Coagulation & Fibrinolysis, 1992
- Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UKBiochemistry, 1992
- A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.Journal of Clinical Investigation, 1991
- Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinaseBiochemical and Biophysical Research Communications, 1990
- Evolutionary Assembly of Blood Coagulation ProteinsSeminars in Thrombosis and Hemostasis, 1990
- Simple canine model of arterial thrombosis with endothelial injury suitable for investigation of thrombolytic agentsJournal of Pharmacological Methods, 1988
- Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarctionThe American Journal of Cardiology, 1986
- Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.Circulation, 1985